Speciality packaging firm the Clondalkin Group has announced its acquisition of Pharmagraphics Inc, one of North America’s largest independent pharmaceutical packaging groups, for US$35m (€28.3m)
Pharmagraphics becomes part of Clondalkin's Specialist Packaging Division, which supplies packaging components to niche markets in Europe and North America. With manufacturing operations in the US, Canada, Puerto Rico and Poland, Pharmagraphics supplies printed leaflets, pressure-sensitive labels, folding cartons and specialist products to the pharma and healthcare markets in America, Canada, Latin America and Eastern Europe.
The company has around 400 staff and a turnover of US$45m (€ 36.4m)
“The acquisition is an excellent strategic fit for Clondalkin as it complements our existing operations and provides us access to fast-growing market segments in new geographical areas,” says John Fitzgerald, ceo of Clondalkin’s Specialist Packaging Division.
Clondalkin already has substantial activities in North America, but the Pharmagraphics transaction is the first for the Specialist Packaging Division in the US since Warburg Pincus acquired Clondalkin Group in 2004. The Division itself has operations in the UK, Ireland, the Netherlands, Poland and the US. Fitzgerald says it is planned to re-brand the Division’s existing healthcare operations, in Ireland and Poland, as Pharmagraphics.
